Literature DB >> 16440413

Inhibitory effect of Polo-like kinase 1 depletion on mitosis and apoptosis of gastric cancer cells.

Xue-Hua Chen1, Bin Lan, Ying Qu, Xiao-Qing Zhang, Qu Cai, Bing-Ya Liu, Zheng-Gang Zhu.   

Abstract

AIM: Polo-like kinase 1 (PLK1) serine/threonine kinase plays a vital role in multiple phases of mitosis in gastric cancer cells. To investigate the effect of PLK1 depletion on mitosis and apoptosis of gastric cancer cells.
METHODS: PLK1 expression was blocked by small RNA interference(siRNA). The expression levels of PLK1, cdc2, cyclin B and caspase 3 were detected by Western blotting. Then, PLK1 depletion, cdc2 activity, cell proliferation, cell cycle phase distribution, mitotic spindle structure, and the rate of apoptosis of the PLK1 knockdown cells were observed.
RESULTS: PLK1 gene knockdown was associated with increased cyclin B expression, increased cdc2 activity (but not with the expression levels), accumulation of gastric cancer cells at G2/M, improper mitotic spindle formation, delayed chromosome separation and delayed or arrested cytokinesis. Moreover, PLK1 depletion in gastric cancer cells was associated with decreased proliferation, attenuated pro-caspase 3 levels and increased apoptosis.
CONCLUSION: Blockage of PLK1 expression may lead to decreased mitosis or even apoptosis in gastric cancer cells, indicating that PLK1 may be a valuable therapeutic target for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440413      PMCID: PMC4077490          DOI: 10.3748/wjg.v12.i1.29

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression.

Authors:  K E Mundt; R M Golsteyn; H A Lane; E A Nigg
Journal:  Biochem Biophys Res Commun       Date:  1997-10-20       Impact factor: 3.575

2.  Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer.

Authors:  G Wolf; R Elez; A Doermer; U Holtrich; H Ackermann; H J Stutte; H M Altmannsberger; H Rübsamen-Waigmann; K Strebhardt
Journal:  Oncogene       Date:  1997-02-06       Impact factor: 9.867

3.  Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells.

Authors:  Xiaoqi Liu; Raymond L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

4.  A role for Plk1 phosphorylation of NudC in cytokinesis.

Authors:  Tianhua Zhou; Jonathan P Aumais; Xiaoqi Liu; Li-Yuan Yu-Lee; Raymond L Erikson
Journal:  Dev Cell       Date:  2003-07       Impact factor: 12.270

5.  Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.

Authors:  Yakir Moshe; Jérôme Boulaire; Michele Pagano; Avram Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

6.  Roles of polo-like kinase 1 in the assembly of functional mitotic spindles.

Authors:  Izabela Sumara; Juan F Giménez-Abián; Daniel Gerlich; Toru Hirota; Claudine Kraft; Consuelo de la Torre; Jan Ellenberg; Jan-Michael Peters
Journal:  Curr Biol       Date:  2004-10-05       Impact factor: 10.834

7.  Polo-like kinase 1 (PLK1) expression is associated with cell proliferative activity and cdc2 expression in malignant lymphoma of the thyroid.

Authors:  Yasuhiro Ito; Hiroshi Yoshida; Fumio Matsuzuka; Nariaki Matsuura; Yasushi Nakamura; Hirokazu Nakamine; Kennichi Kakudo; Kanji Kuma; Akira Miyauchi
Journal:  Anticancer Res       Date:  2004 Jan-Feb       Impact factor: 2.480

8.  Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation.

Authors:  Kiyohiro Ando; Toshinori Ozaki; Hideki Yamamoto; Kazushige Furuya; Mitsuchika Hosoda; Syunji Hayashi; Masahiro Fukuzawa; Akira Nakagawara
Journal:  J Biol Chem       Date:  2004-03-15       Impact factor: 5.157

9.  Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression.

Authors:  MiYoung Lee; Matthew J Daniels; Ashok R Venkitaraman
Journal:  Oncogene       Date:  2004-01-29       Impact factor: 9.867

10.  Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5.

Authors:  R M Golsteyn; S J Schultz; J Bartek; A Ziemiecki; T Ried; E A Nigg
Journal:  J Cell Sci       Date:  1994-06       Impact factor: 5.285

View more
  6 in total

Review 1.  Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications.

Authors:  Ion Cristóbal; Federico Rojo; Juan Madoz-Gúrpide; Jesús García-Foncillas
Journal:  Mol Cell Biol       Date:  2016-05-31       Impact factor: 4.272

2.  Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients.

Authors:  Zi-Li He; He Zheng; Hui Lin; Xiong-Ying Miao; De-Wu Zhong
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

3.  A series of beta-carboline derivatives inhibit the kinase activity of PLKs.

Authors:  Xiaomin Han; Jing Zhang; Liang Guo; Rihui Cao; Yongzhen Li; Ni Li; Qin Ma; Jialin Wu; Yanchang Wang; Shuyi Si
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

4.  Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells.

Authors:  Ding-pei Han; Qian-lin Zhu; Jiang-tao Cui; Pu-xiongzhi Wang; Shun Qu; Qi-feng Cao; Ya-ping Zong; Bo Feng; Min-hua Zheng; Ai-guo Lu
Journal:  Med Sci Monit       Date:  2012-06

5.  Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell lines.

Authors:  Denise L Driscoll; Arijit Chakravarty; Doug Bowman; Vaishali Shinde; Kerri Lasky; Judy Shi; Tricia Vos; Bradley Stringer; Ben Amidon; Natalie D'Amore; Marc L Hyer
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

6.  The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation.

Authors:  Peng Lin; Dan-Dan Xiong; Yi-Wu Dang; Hong Yang; Yun He; Dong-Yue Wen; Xin-Gan Qin; Gang Chen
Journal:  Oncotarget       Date:  2017-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.